Lee Hambright
Stock Analyst at Bernstein
(0.50)
# 4,165
Out of 4,575 analysts
190
Total ratings
45.9%
Success rate
-4.5%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Rated: Buy | $750 → $685 | $337.50 | +102.96% | 28 | Jul 17, 2026 | |
| MDT Medtronic | Maintained: Buy | $112 → $97 | $83.21 | +16.57% | 24 | Jun 4, 2026 | |
| DXCM DexCom | Maintained: Buy | $77 | $71.54 | +7.63% | 18 | May 15, 2026 | |
| PODD Insulet | Rated: Buy | $330 → $200 | $163.26 | +22.50% | 13 | May 7, 2026 | |
| MDLN Medline | Rated: Buy | $56 → $54 | $38.75 | +39.35% | 3 | May 7, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $410 | $330.25 | +24.15% | 15 | May 1, 2026 | |
| JNJ Johnson & Johnson | Maintained: Hold | n/a | $263.40 | - | 21 | Apr 14, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $130 → $112 | $44.25 | +153.11% | 18 | Feb 5, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $154 → $125 | $103.06 | +21.29% | 16 | Jan 23, 2026 | |
| EW Edwards Lifesciences | Maintained: Hold | n/a | $82.63 | - | 12 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $99 | $91.35 | +8.37% | 15 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.12 | - | 7 | Jan 16, 2026 |
Intuitive Surgical
Jul 17, 2026
Rated: Buy
Price Target: $750 → $685
Current: $337.50
Upside: +102.96%
Medtronic
Jun 4, 2026
Maintained: Buy
Price Target: $112 → $97
Current: $83.21
Upside: +16.57%
DexCom
May 15, 2026
Maintained: Buy
Price Target: $77
Current: $71.54
Upside: +7.63%
Insulet
May 7, 2026
Rated: Buy
Price Target: $330 → $200
Current: $163.26
Upside: +22.50%
Medline
May 7, 2026
Rated: Buy
Price Target: $56 → $54
Current: $38.75
Upside: +39.35%
Stryker
May 1, 2026
Maintained: Buy
Price Target: $465 → $410
Current: $330.25
Upside: +24.15%
Johnson & Johnson
Apr 14, 2026
Maintained: Hold
Price Target: n/a
Current: $263.40
Upside: -
Boston Scientific
Feb 5, 2026
Maintained: Buy
Price Target: $130 → $112
Current: $44.25
Upside: +153.11%
Abbott Laboratories
Jan 23, 2026
Maintained: Buy
Price Target: $154 → $125
Current: $103.06
Upside: +21.29%
Edwards Lifesciences
Jan 16, 2026
Maintained: Hold
Price Target: n/a
Current: $82.63
Upside: -
Jan 16, 2026
Rated: Hold
Price Target: $99
Current: $91.35
Upside: +8.37%
Jan 16, 2026
Maintained: Hold
Price Target: n/a
Current: $17.12
Upside: -